Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.8%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
The objective of this work was to investigate the feasibility of using 0 mm PTV margin in online adaptive radiotherapy for the first fractions, in combination with treatment-specific local compensatio
APA
van der Bijl E, Jan Smeenk R, et al. (2025). Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.. Physics in medicine and biology, 70(11). https://doi.org/10.1088/1361-6560/add984
MLA
van der Bijl E, et al.. "Dose adaptation to compensate for cumulative intra-fraction motion effects in online adaptive radiotherapy.." Physics in medicine and biology, vol. 70, no. 11, 2025.
PMID
40373803 ↗
Abstract 한글 요약
The objective of this work was to investigate the feasibility of using 0 mm PTV margin in online adaptive radiotherapy for the first fractions, in combination with treatment-specific local compensation of accumulated underdosage to the target in the last fraction.Intrafraction motion patterns and delineations of twelve patients with prostate cancer were selected to cover a range of observed systematic and random inter- and intrafraction motion patterns. Treatment plans with 0 and 3 mm margins were created and dose was accumulated rigidly using the observed motion patterns. For the dose-adaptation approach a plan was created for the last treatment fraction locally compensating for dose missed in the previous fractions. Robustness of the accumulation was estimated by simulating treatments with random registration errors added to the observed registrations, with standard deviations of 0.5 and 1.0 mm.Target coverage of the dose-adaptive workflow was not-significantly below the standard approach, and at the desired level but for the two patients with the largest systematic prostate motion. The near-maximum dose to the organs at risk is lowered for all patients with a median of 1.5 Gy. The total volume receiving 95% of the prescribed dose was reduced by 15% to 1.6 times the clinical target volume indicating better conformity, at the cost of an increased near-maximum dose to the target. However, the dose-adaptive plan was less robust leading to a median 0.5% decrease in dose to the target also with decreasing robustness with larger motion patterns.The results demonstrate that a post-hoc correction of missed dose leads to an overall lower dose to nearby organs at risk at the cost of target dose near-maximum dose, making it a feasible approach for consideration.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.